Vaxart Inc banner

Vaxart Inc
NASDAQ:VXRT

Watchlist Manager
Vaxart Inc Logo
Vaxart Inc
NASDAQ:VXRT
Watchlist
Price: 0.7295 USD 7.28% Market Closed
Market Cap: $175.5m

Wall Street
Price Targets

VXRT Price Targets Summary
Vaxart Inc

Wall Street analysts forecast VXRT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VXRT is 4.08 USD with a low forecast of 4.04 USD and a high forecast of 4.2 USD.

Lowest
Price Target
4.04 USD
454% Upside
Average
Price Target
4.08 USD
459% Upside
Highest
Price Target
4.2 USD
476% Upside
Vaxart Inc Competitors:
Price Targets
CENT
Central Garden & Pet Co
31% Upside
CASY
Caseys General Stores Inc
0% Downside
WOOF
Petco Health and Wellness Company Inc
22% Upside
HCAT
Health Catalyst Inc
63% Upside
INBK
First Internet Bancorp
14% Upside
FULT
Fulton Financial Corp
9% Upside

Revenue
Forecast

78% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
78% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss

For the last 7 years the compound annual growth rate for Vaxart Inc's revenue is 78%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VXRT's stock price target?
Price Target
4.08 USD

According to Wall Street analysts, the average 1-year price target for VXRT is 4.08 USD with a low forecast of 4.04 USD and a high forecast of 4.2 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett